Plutux
$35.32
-0.95%
2026-09-04 09:41:39 EDT-$0.34
Healthcare
Biotechnology
NASDAQ
Active Trading

Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema ...

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026